Europe Mycoplasma Testing Market by Product (Kits & Reagents, Instruments and services), by Technique (PCR, ELSA, Direct Assays, Indirect Assays, Microbial culture techniques, Enzymatic Methods, and DNA Staining), by Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and others), by End User (Pharmaceutical Companies, Contract research organizations, Academic Research Institutes and Cell Banks) and by Region
- Advertising -
The Europe mycoplasma testing market was worth USD 111.6 Million in 2016 and is estimated to be growing at a CAGR of 12.6%, to reach USD 202.07 Million by 2021. Mycoplasma is a prokaryotic organism which is often responsible for the contamination of cell cultures.
This organism has the ability to alter certain features of cell physiology resulting in the invalidity of the experiments conducted.
View Full Report at www.marketdataforecast.com/market-…ting-market-3664/
Because of its small size, they easily pass through filters that usually prevent contamination from fungus and bacteria and easily spread to other cell cultures in the laboratory.
- Advertising -
Hence, it is necessary that cell cultures entering a laboratory are to be tested to detect the presence of mycoplasma and the laboratory itself is also to be tested. There are many mycoplasma testing methods available in the market.
Rising expenditure for research and development activities in pharmaceutical and biotechnology companies, increased R&D activities in life sciences and increasing incidence of mycoplasma infections in cell cultures are the major factors driving the growth of mycoplasma testing market in Europe region. High degree of market consolidation and increase in expenditure for mycoplasma testing are the major restraining factors for the market.
- Kits & Reagent
- o PCR Assays
- o Nucleic Acid Detection Kits
- o Elimination Kits & Reagents
- o Stains
- o Standards & Controls
- o Other Kits & Reagents
- Direct Assays
- Indirect Assays
- Microbial culture techniques
- Enzymatic Methods
- DNA Staining
- Cell Line Testing
- Virus Testing
- End-Of-Production Cell Testing
- Other Applications
- Pharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
- Cell Banks
Based on geography, the Europe market for mycoplasma testing is segmented into UK, Germany, France, Spain and Italy regions. Germany leads the mycoplasma testing market owing to the increase in number of pharmaceutical industries in this region.
The major companies in the mycoplasma testing market are Thermo Fisher Scientific Inc., American Type Culture Collection, Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Biological Industries Israel Beit Haemek Ltd., Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., InvivoGen, PromoCell GmbH, and WuXi AppTec.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: